持田製薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4534/E00947-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2025/05/09日証協無担保0株0.00%0株0.00%100株-99.06%
2025/05/09日証協有担保150,166株+52.80%1,243株-72.63%9,248株+30.68%
2025/05/02日証協無担保0株-100.00%0株0.00%10,628株+866.18%
2025/05/02日証協有担保98,276株-36.68%4,542株-71.25%7,077株-65.97%
2025/04/25日証協無担保700株-85.71%0株0.00%1,100株+1000.00%
2025/04/25日証協有担保155,201株+2.86%15,800株+122.54%20,796株+58.17%
2025/04/18日証協無担保4,900株+19.51%0株0.00%100株-95.84%
2025/04/18日証協有担保150,893株-49.86%7,100株+32.78%13,148株-85.64%
2025/04/11日証協無担保4,100株-46.41%0株0.00%2,401株-51.99%
2025/04/11日証協有担保300,964株+64.44%5,347株+262.26%91,576株+54.20%
2025/04/04日証協無担保7,650株+325.00%0株0.00%5,001株-16.82%
2025/04/04日証協有担保183,019株+68.81%1,476株-76.19%59,388株+226.74%
2025/03/28日証協無担保1,800株-59.09%0株0.00%6,012株+9999.99%
2025/03/28日証協有担保108,420株-26.96%6,200株-80.70%18,176株-82.06%
2025/03/21日証協無担保4,400株+37.50%0株0.00%10株-95.00%
2025/03/21日証協有担保148,434株-34.20%32,123株+202.28%101,306株+688.86%
2025/03/14日証協無担保3,200株-64.16%0株0.00%200株-50.12%
2025/03/14日証協有担保225,583株-29.51%10,627株+50.42%12,842株-6.28%
2025/03/07日証協無担保8,928株-3.78%0株0.00%401株+301.00%
2025/03/07日証協有担保320,032株+142.78%7,065株+50.32%13,702株+100.50%
2025/02/28日証協無担保9,279株0.00%0株0.00%100株-66.67%
2025/02/28日証協有担保131,822株-7.92%4,700株+150.93%6,834株+13.90%
2025/02/21日証協無担保0株-100.00%0株0.00%300株-25.00%
2025/02/21日証協有担保143,162株-42.39%1,873株-82.90%6,000株-36.40%
2025/02/14日証協無担保31,297株0.00%0株0.00%400株+300.00%
2025/02/14日証協有担保248,488株+37.99%10,953株+212.94%9,434株+177.47%
2025/02/07日証協無担保0株0.00%0株0.00%100株0.00%
2025/02/07日証協有担保180,083株+29.43%3,500株+94.44%3,400株-73.46%
2025/01/31日証協無担保0株0.00%0株0.00%100株0.00%
2025/01/31日証協有担保139,140株+10.84%1,800株+411.36%12,812株+141.33%
2025/01/24日証協無担保0株0.00%0株0.00%100株-85.71%
2025/01/24日証協有担保125,530株-28.83%352株-48.46%5,309株+88.80%
2025/01/17日証協無担保0株0.00%0株0.00%700株-63.16%
2025/01/17日証協有担保176,392株-23.18%683株-80.92%2,812株-91.13%
2025/01/10日証協無担保0株0.00%0株0.00%1,900株+533.33%
2025/01/10日証協有担保229,605株+226.68%3,579株+4609.21%31,687株+508.20%
2024/12/30日証協有担保70,284株-76.67%76株-97.47%5,210株-48.92%

※株式分割は考慮していませんのでご注意ください。

Page Top